Here's Why You Should Retain Ingersoll Rand in Your Portfolio

Core Insights - Ingersoll Rand Inc. (IR) is experiencing increased orders across its industrial vacuums and blowers, leading to a 7.2% year-over-year growth in the Industrial Technologies & Services (IT&S) segment, totaling $1.52 billion in orders for Q3 2025 [1] - The Precision and Science Technologies segment reported an 11.1% year-over-year increase in orders, reaching $420.1 million, driven by strong momentum in the life sciences business and demand for biopharma solutions [2] - The company is actively expanding its portfolio through acquisitions, including Transvac Systems Ltd., Dave Barry Plastics, and Lead Fluid, which enhance its life sciences and engineered solutions offerings [3][4] Financial Performance - In the first nine months of 2025, Ingersoll Rand generated free cash flow of $758.6 million, a slight increase of 0.3% year over year, while returning $24 million in dividends and repurchasing $703 million in treasury stocks [5] - Acquisitions contributed 4.7% to total revenues in Q3 2025, reflecting the positive impact of strategic buyouts on financial performance [4] Cost and Debt Concerns - The company is facing rising operating costs, with the cost of sales increasing by 4.4% year over year in the first nine months of 2025, alongside a 5.6% rise in selling and administrative expenses in 2024 [9][10] - As of Q3 2025, Ingersoll Rand's long-term debt stood at $4.79 billion, with interest expenses of $65.1 million, marking a 2% increase year over year [11]